Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction

Heart failure (HF) is a growing healthcare issue in developed countries due to its high prevalence, mortality, morbidity, and cost of care. In the United States, the population prevalence of HF was 2.42% in 2012 and is projected to increase by 23% in 2030 to 2.97% (1)